NEW YORK – Investigators at Ambry Genetics, the Mayo Clinic in Rochester, the University of Utah, and the University of California at Irvine have tapped into Ambry’s large collection of multigene panel test results to clarify hereditary cancer associations in high-risk patients — identifying gene-specific cancer associations they hope will inform future hereditary cancer test guidance.
To read the full article, click here.